StockData
Repligen Corp logo

Repligen Corp (RGEN) stock

RGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 7/30132% above fair value
$162.18−0.60 (-0.37%)

Close on Nov 17, 2026Market cap $10.37BP/E –Yield –

Repligen profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Repligen's profit margin for the twelve months ending Sep 30, 2026 was -1.5%. For fiscal 2025 it was 6.6%, against -4.0% the year before. The highest annual figure on record is 23.6% in fiscal 2013.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20256.6%+10.6
FY2024Dec 31, 2024-4.0%−9.7
FY2023Dec 31, 20235.6%−17.6
FY2022Dec 31, 202223.2%+4.1
FY2021Dec 31, 202119.1%+2.8
FY2020Dec 31, 202016.4%+8.4
FY2019Dec 31, 20197.9%−0.6
FY2018Dec 31, 20188.6%−11.5
FY2017Dec 31, 201720.1%+8.9
FY2016Dec 31, 201611.2%−0.0
FY2015Dec 31, 201511.2%−1.7
FY2014Dec 31, 201412.9%−10.8
FY2013Dec 31, 201323.6%+23.8
FY2011Mar 31, 2011-0.2%+19.2
FY2010Mar 31, 2010-19.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-18.4%−26.3
Q2 FY2026Jun 30, 20262.5%−5.7
Q1 FY2026Mar 31, 20264.3%+0.8
Q4 FY2025Dec 31, 20256.7%+26.9
Q3 FY2025Sep 30, 20257.9%+8.3
Q2 FY2025Jun 30, 20258.2%+4.6
Q1 FY2025Mar 31, 20253.4%+1.3
Q4 FY2024Dec 31, 2024-20.2%−10.3
Q3 FY2024Sep 30, 2024-0.4%−12.4
Q2 FY2024Jun 30, 20243.6%−8.8
Q1 FY2024Mar 31, 20242.2%−7.1
Q4 FY2023Dec 31, 2023-9.9%−36.0
Q3 FY2023Sep 30, 202312.0%−8.1
Q2 FY2023Jun 30, 202312.4%−11.6
Q1 FY2023Mar 31, 20239.3%−13.5
Q4 FY2022Dec 31, 202226.1%+10.5
Q3 FY2022Sep 30, 202220.1%+1.3
Q2 FY2022Jun 30, 202224.0%+1.8
Q1 FY2022Mar 31, 202222.8%+2.1
Q4 FY2021Dec 31, 202115.6%−2.5
Q3 FY2021Sep 30, 202118.8%+3.3
Q2 FY2021Jun 30, 202122.2%+4.1
Q1 FY2021Mar 31, 202120.6%+7.7
Q4 FY2020Dec 31, 202018.1%+12.9
Q3 FY2020Sep 30, 202015.5%+13.1
Q2 FY2020Jun 30, 202018.1%+6.7
Q1 FY2020Mar 31, 202012.9%−0.4
Q4 FY2019Dec 31, 20195.2%−5.7
Q3 FY2019Sep 30, 20192.4%−7.3
Q2 FY2019Jun 30, 201911.5%+5.7
Q1 FY2019Mar 31, 201913.3%+5.6
Q4 FY2018Dec 31, 201810.9%−18.4
Q3 FY2018Sep 30, 20189.7%−3.1
Q2 FY2018Jun 30, 20185.7%−20.3
Q1 FY2018Mar 31, 20187.7%−2.3
Q4 FY2017Dec 31, 201729.3%+9.6
Q3 FY2017Sep 30, 201712.8%–
Q2 FY2017Jun 30, 201726.0%–
Q1 FY2017Mar 31, 201710.0%–
Q4 FY2016Dec 31, 201619.6%–

More Repligen figures

See a number that looks wrong?